← Back to Search

Procedure

Closed vs. Open Abdomen Management for Sepsis

N/A
Recruiting
Led By Andrew W Kirkpatrick, MD
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Septic shock
Be older than 18 years old
Must not have
Pancreatitis as the source of peritonitis
Uncontrolled bleeding
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 72 hours after participants enrolled in the study
Awards & highlights

Summary

This trial is designed to study which procedure is better: primarily closing the fascia after laparotomy for intra-abdominal infection (CLOSED), or leaving the fascia open and applying a temporary abdominal closure device (OPEN) with a vacuum drain.

Who is the study for?
This trial is for adults with severe abdominal sepsis, indicated by specific scores like the World-Society-of-Emergency-Surgery-Sepsis-Severity Score >8. It's not for pregnant individuals, those with high intra-abdominal pressure (IAP>20 mmHg), patients without plans for continued care, cases of pancreatitis-induced peritonitis, or uncontrolled bleeding.
What is being tested?
The study compares two methods to manage abdominal infections after surgery: 'Closed Abdomen Management' where the surgical cut is closed right away and 'Open Abdomen Management' where it's left open with a vacuum dressing applied. Participants are randomly assigned to one of these treatments.
What are the potential side effects?
Potential side effects may include complications from wound healing, infection risks due to an open abdomen, discomfort associated with dressings or drains used in treatment, and possible need for additional surgeries.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am currently experiencing septic shock.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My peritonitis is caused by pancreatitis.
Select...
I do not have any ongoing issues with uncontrolled bleeding.
Select...
I do not plan to continue receiving treatment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~72 hours after participants enrolled in the study
This trial's timeline: 3 weeks for screening, Varies for treatment, and 72 hours after participants enrolled in the study for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
The numbers of participants who are survival in hospital stay
Secondary study objectives
The days of intensive care unit stay
The pg/ml of blood Interleukin-6

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Open Abdomen Management with ANPPT dressingActive Control1 Intervention
The abdominal fascia will not be closed, but a temporally abdomenal closure (TAC) dressing (such as AbThera dressing) will be placed to protect the viscera with active Negative Pressure Peritoneal drain. Formal abdominal closure or dressing change at 24-72 hours from placement should be performed.
Group II: Closed Abdomen ManagementPlacebo Group1 Intervention
Primary closure of the abdominal fascia with placement of an intra-peritoneal drain (such as a Jackson-Pratt drain). Any decision to perform a re-laparotomy will be at the discretion of the treating surgical team.

Find a Location

Who is running the clinical trial?

Alberta Health servicesOTHER
162 Previous Clinical Trials
650,464 Total Patients Enrolled
1 Trials studying Sepsis
50 Patients Enrolled for Sepsis
University of CalgaryLead Sponsor
805 Previous Clinical Trials
883,482 Total Patients Enrolled
2 Trials studying Sepsis
196 Patients Enrolled for Sepsis
Andrew W Kirkpatrick, MDPrincipal InvestigatorUniversity of Calgary
2 Previous Clinical Trials
195 Total Patients Enrolled
1 Trials studying Sepsis
50 Patients Enrolled for Sepsis

Media Library

Closed Abdomen Management (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT03163095 — N/A
Sepsis Research Study Groups: Open Abdomen Management with ANPPT dressing, Closed Abdomen Management
Sepsis Clinical Trial 2023: Closed Abdomen Management Highlights & Side Effects. Trial Name: NCT03163095 — N/A
Closed Abdomen Management (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03163095 — N/A
~69 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top